Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.

  • Read more about LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.

Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.

  • Read more about Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.

Three-year results from phase 1 of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.

  • Read more about Three-year results from phase 1 of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

  • Read more about Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.

  • Read more about The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment.

Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.

  • Read more about Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.

A new target for fetal hemoglobin reactivation.

  • Read more about A new target for fetal hemoglobin reactivation.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

  • Read more about Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.

  • Read more about Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.

  • Read more about Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.

Pagination

  • Page 1
  • Next page ››
Subscribe to Haematologica

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List